Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

NYSE:AMRX   3:59:59 PM EDT
3.98
-0.12 (-2.93%)
Other Pre-Announcement

Amneal Pharmaceuticals Q3 Loss Per Share $0.06

Published: 11/06/2020 11:15 GMT
Amneal Pharmaceuticals Inc (AMRX) - Amneal Reports Third Quarter 2020 Financial Results.
Q3 Loss per Share $0.06.
Q3 Revenue $519 Million Versus Refinitiv Ibes Estimate of $482.1 Million.
Q3 Earnings per Share Estimate $0.12 -- Refinitiv Ibes Data (analyst estimates).
Q3 Adjusted Earnings per Share $0.16.
Updating Full Year 2020 Financial Outlook.
Sees 2020 FY Net Revenue $1,950 Million - $2,000 Million.
Sees 2020 FY Adjusted EBITDA $430 Million - $460 Million.
Sees 2020 FY Adjusted Diluted EPS $0.55 - $0.65.
Net Revenue in Q3 of 2020 Was $519 Million, an Increase of 37% Compared to $378 Million in Q3 of 2019.